Intrinsic Value of S&P & Nasdaq Contact Us

Becton, Dickinson and Company BDX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$318.86
+104.8%
Analyst Price Target
$193.80
+24.4%

Becton, Dickinson and Company (BDX) — Analyst outlook / Analyst consensus target is. Based on 33 analyst ratings, the consensus is bullish — 16 Buy, 16 Hold, 1 Sell.

The consensus price target is $193.80 (low: $170.00, high: $215.00), representing an upside of 24.4% from the current price $155.73.

Analysts estimate Earnings Per Share (EPS) of $10.30 and revenue of $20.17B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $5.88 vs est $10.30 (missed -42.9%). 2025: actual $5.84 vs est $11.30 (missed -48.3%). Analyst accuracy: 16%.

BDX Stock — 12-Month Price Forecast

$193.80
▲ +24.45% Upside
Average Price Target
Based on 33 Wall Street analysts offering 12-month price targets for Becton, Dickinson and Company, the average price target is $193.80, with a high forecast of $215.00, and a low forecast of $170.00.
The average price target represents a +24.45% change from the last price of $155.73.
Highest Price Target
$215.00
Average Price Target
$193.80
Lowest Price Target
$170.00

BDX Analyst Ratings

Buy
33
Ratings
16 Buy
16 Hold
1 Sell
Based on 33 analysts giving stock ratings to Becton, Dickinson and Company in the past 3 months
Rating breakdown
Buy
16 48%
Hold
16 48%
Sell
1 3%
48%
Buy
16 analysts
48%
Hold
16 analysts
3%
Sell
1 analysts

EPS Estimates — BDX

16%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $5.88 vs Est $10.30 ▼ 75.2% off
2025 Actual $5.84 vs Est $11.30 ▼ 93.5% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — BDX

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $20.178B vs Est $20.170B ▲ 0.0% off
2025 Actual $21.839B vs Est $21.858B ▼ 0.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message